Insulet Corp. logo
PODDInsulet Corp.

Average Current Ratio

Current Ratio

The latest reported current ratio is 2.49 as of Tuesday, March 31, 2026, shown against its trailing averages.

PODD Current Ratio

PODD Average Current Ratio

PODD Current Ratio Averages

CURRENT RATIO LATEST REPORTED

2.49

CURRENT RATIO TTM

2.96

CURRENT RATIO 3Y

3.28

CURRENT RATIO 5Y

4.02

CURRENT RATIO 10Y

4.74

CURRENT RATIO 15Y

4.59

CURRENT RATIO 20Y

4.67

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy